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INTRODUCTION
Botulinum toxin is the etiologic agent that causes the disease botulism. Botulinum toxin acts mainly on peripheral cholinergic nerve cells, where its principal effect is to block exocytosis (Simpson, 2004) . Thus, all signs and symptoms of botulism can be explained on the basis of peripheral blockade of acetylcholine release. For example, flaccid paralysis and possible respiratory arrest can be attributed to blockade of exocytosis at neuromuscular junctions, and phenomena such as loss of salivation, gastrointestinal stasis and urinary retention are due to blockade of exocytosis at various autonomic sites.
The fact that botulinum toxin acts at exquisitely low concentrations to paralyze transmission has prompted efforts to decipher its actions on nerve endings and transmitter release. This effort has culminated in a relatively complete understanding of the basis for its toxicity (Herreros et al., 1999; Humeau et al., 2000; Simpson, 2004) . The data indicate that toxin action on nerve cells can be envisioned as a sequence of steps, including: 1) binding to receptors on the membranes of nerve endings, 2) productive internalization via receptormediated endocytosis, 3) pH-induced translocation to the cytosol, and 4) zinc-dependent endoprotease activity to cleave polypeptides that are essential for exocytosis. There is an JPET #92213 culminated in a model for toxin action that involves binding to receptors on the apical (mucosal) surface of gut epithelial cells, followed by transcytosis and delivery to the basolateral (serosal) side of these cells. Transcytosis is energy dependent, and it delivers toxin to the trans side of cells in the same conformation that binds to the cis side.
In the work that follows, an attempt has been made to visualize the process of binding, transcytosis and release of botulinum toxin by a human gut epithelial cell line (T-84) . This represents the first attempt to visualize the sequence of events from toxin association on one side of polarized cells to eventual release on the other side of cells. Indeed, this is the first attempt to visualize the ability of any bacterial toxin to completely traverse an epithelial barrier.
The resulting data provide essential insights about toxin transport across epithelial barriers that could not have been obtained using the earlier technique of kinetic analysis (Maksymowych and Simpson, 1998; 2004) . However, when taken in the aggregate, the kinetic data and the visualization data provide a reasonably clear picture of the process by which botulinum toxin enters the body to exert its pharmacologic effects.
JPET #92213
Labeling of botulinum neurotoxin. Purified toxin was labeled with Alexa Fluor TM 488
Protein Labeling Kit (Molecular Probes, Oregon), essentially according to manufacturer's instructions. The only notable modification was that the toxin was allowed to mix with the reactive dye for 30 min (instead of 60 min) at room temperature. Labeled toxin was separated from free dye by column chromatography, and the degree of labeling was determined from the following calculations:
[A 280 -(A 494 x 0.
11)] x dilution factor Protein concentration (M) = -----------------------------------------------------
(eq. 1) 244, 499 where 244,499 is the molar extinction coefficient of pure botulinum neurotoxin, and 0.11 is a correction factor to account for absorption of the Alexa 488 dye at 280 nm.
A 494 x dilution factor Moles dye per mole protein = --------------------------------------------
(eq. 2) 71,000 x protein concentration (M) where 71,000 is the approximate molar extinction coefficient of the Alexa TM Fluor 488 dye at 494 nm. The moles of dye per mole of labeled toxin averaged 7.5.
In vivo and in vitro toxicity testing of the labeled toxin. The toxicity of the labeled material was bioassayed either by intraperitoneal injection into mice or by addition to mouse phrenic nerve-hemidiaphragm preparations (Simpson et al., 2001) . For the in vivo bioassay, 1 µg of labeled or native botulinum toxin was administered in a 100 µl aliquot of phosphate buffered saline (PBS). Animals (group n=8) were monitored for survival for a period of 6 hr. For the in vitro bioassay, tissues were excised and suspended in physiological buffer that was aerated with 95% O 2 , 5% CO 2 and maintained at 35 o C (Simpson et al., 2001) . Phrenic nerves were stimulated continuously (1.0 Hz; 0.1-0.3 ms duration), and muscle twitch was recorded.
This article has not been copyedited and formatted. The final version may differ from this version. Labeled or native toxin (1x10 -11 M) was added to tissues (group n=4 each), and paralysis was measured as a 50% reduction in muscle twitch response to neurogenic stimulation.
SNAP-25 cleavage assay. Construction and expression of recombinant GST-SNAP-25
(~50 kDa), as well as its use as a substrate for botulinum toxin, have been described previously (Simpson et al., 2001 Conditions for fluorescence imaging. T-84 cells were grown on rat tail collagen-coated 8-well culture slides (Beckton Dickinson) for 18-24 h at 37 o C, followed by slow cooling to 3 o C (~ 1 hr). The cells were rinsed with ice cold PBS containing 1% BSA and incubated at 3 o C for 2 hr with different dilutions of the labeled toxin (10 -9 -10 -6 M). After three washes with ice cold PBS-BSA, the cells were fixed with freshly prepared 4% paraformaldehyde for 15 min. The paraformaldehyde was decanted off, followed by washing with PBS only. Cover glasses were
This article has not been copyedited and formatted. The final version may differ from this version. 
RESULTS
Purification, labeling and bioassay of toxin preparations. Botulinum toxin type A was
isolated by conventional techniques (DasGupta and Sathyamoorthy, 1984; Simpson et al., 1988) . As judged by scanning densitometry of SDS-PAGE gels of the final product, the toxin was greater than 95% homogeneous. This material was labeled with Alexa Fluor 488 according to manufacturers instructions. However, this produced a higher than necessary ratio of moles of dye to mole of toxin, which in turn appeared to cause an unacceptable loss of pharmacologic activity. Therefore, reaction conditions were slightly modified (i.e., shorter incubation time; 30 min), resulting in a final product with an average ratio of moles of dye per mole of toxin of ca 7.5.
The fluorescent dye has a succinimidyl ester moeity that reacted with primary amines of proteins to form a dye~toxin conjugate. This chimeric molecule was stable and usable for at least three months.
Both in vivo and in vitro experiments were done to assess residual toxicity of the dye~toxin complex. For in vivo experiments, animals (group n=3) were challenged intraperitoneally with 1 µg of toxin (or toxin equivalent for dye~complex). The mean survival time of animals receiving untreated toxin was 75 ± 5 min; that of animals receiving dye~toxin complex, 90 ± 19 min (p > 0.05). For in vitro experiments, a concentration of 1 x 10 -11 M toxin was added to isolated phrenic nerve-hemidiaphragm preparations (group n=3), and paralysis times were monitored. The results for native toxin and for complex, respectively, were 46 ± 3 min and 53 ± 6 min (p > 0.05). These results make clear that limited modification of primary amines did not abolish the biological activity of botulinum toxin.
SNAP-25 cleavage assay.
As a further test of residual activity, the dye~toxin complex was assayed for its ability to cleave SNAP-25. As shown in Figure 1 , the chimeric molecule retained enzymatic activity, and its ability to cleave SNAP-25 was comparable to that of native toxin.
This article has not been copyedited and formatted. The final version may differ from this version. Concentration of labeled toxin. Several preliminary experiments were performed to determine the optimum concentration of dye~toxin complex for visualization of binding to cells.
Various concentrations of the complex (10 -9 to 10 -6 M) were incubated with cultures of T-84 cells for 2 hr at 3°C. The duration of incubation was sufficient to ensure that binding had reached equilibrium (see below). Cells were then washed with iced medium to remove any loosely associated material.
Examination of cells for amount and distribution of binding provided three major findings.
First, auto-fluorescence from T-84 cells, under conditions that pertain to detection of the Alexa dye, was very low and did not impede efforts to detect the dye~toxin complex. Second, cell association of the dye~toxin complex with the surface of T-84 cells could be measured over the entire concentration range (Fig. 2) . However, a maximum fluorescence was attained in the vicinity of 1 x10 -7 M. Unless otherwise stated, this is the concentration that was employed in subsequent studies. Third, binding sites for the toxin were not localized in any particular region.
To the contrary, binding appeared to be distributed across the cell surface. This was true, regardless of toxin concentration, which indicates that there was no concentration-dependent binding to any specific domain on the cell surface.
Rate of toxin association with cells. The prospects for visualizing toxin internalization
and transport across cells can be maximized in two ways: 1.) ensuring that there is saturation or near-saturation of binding sites on the cell surface, while 2.) ensuring that bound toxin remains at the cell surface until the internalization process is initiated. The latter is especially important, because it allows one to synchronize a single wave of toxin movement through all cells in a monolayer (see below).
To determine the timecourse for dye~toxin association with cell surface receptors, T-84 cells grown on culture plates were cooled to 3°C (to prevent receptor-mediated endocytosis), then exposed to the labeled toxin (1 x 10 -7 M) for varying lengths of time (0 to 120 min). After exposure, cells were gently washed (3x) with iced PBS-BSA, fixed with 4% paraformaldehyde, (Fig 3) . The rate of approach to asymptote indicated a half-time for association of 30 to 40 min.
Rate of toxin dissociation from cells. Toxin dissociation from neuronal receptors on
intact cells is known to be slow (Schiavo et al., 2000; Habermann and Dreyer, 1986; Wellhöner, 1992; Halpern and Neale, 1995) . The phenomenon of toxin dissociation from epithelial cells has not been previously described. min, whereas the others were maintained at 37°C. At the end of this process, all cells were washed and transferred to medium at 37°C. Transcytosis was initiated by adding dye~toxin complex, and the rate of appearance on the contralateral side of monolayers was monitored.
The data revealed that labeled toxin began to appear in all of the lower wells within the same amount of time (ca. 5 min). There was no evidence for a slower rate of transcytosis in cells that had been transiently cooled.
Visualization of binding and transcytosis.
T-84 cells were grown on culture inserts, then exposed to toxin under conditions that maximize binding (as above). After washing, cells were exposed to medium at physiological temperature to trigger internalization. At various times after warming, cells were submitted to serial confocal sectioning at 2 µm increments.
As shown in Figure 6 , toxin association with cells at time 0 min was concentrated at the apical cell surface. Serial sections through cells revealed progressively lesser amounts of dye~toxin with progressively greater depth. Optical slicing always revealed small patches of labeling outside the field of the cell of interest, which at least in part was due to neighboring cells that were not the same height.
Within 5 min of initiating internalization, a substantial fraction of the dye complex at the cell surface had entered cells and made progress in transcytosis from the apical to the basolateral surface. There were two major observations that emerged from these images.
First, although the only toxin that was available for internalization was that already bound to the cell surface, this toxin was not internalized as a single pool. In as little as 5 min, fractions of the total pool were distributed throughout most of the cell. One implication of this finding is that at saturation of binding, the number of toxin~receptor complexes is greater than can be accommodated, or more disperse than can be accommodated, by a single simultaneous wave of receptor-mediated endocytosis.
The second observation pertains to the morphology of human gut epithelial cells. As shown in Figure 6 , toxin that had left the surface and approached the middle of the cell assumed a "halo-like" appearance. This outcome was a by-product of cell anatomy. Human gut epithelial cells possess unusually large, centrally located nuclei, and this of necessity displaces transcytotic vesicles to the periphery (Madara et al., 1987) . The unusually large size of these nuclei is illustrated in the phase contrast images (Fig. 6 ).
Within 10 min of initiating internalization, all or nearly all of the toxin had left the surface and was localized at the midline or lower. Clearly, some fraction of the molecules had already reached the basal surface and was available for release. As before, toxin in the midsection of the cell assumed a halo-like appearance, but toxin toward the bottom of the cell -which presumably had progressed beyond the nucleus -was distributed across the cell width.
The pattern of labeling at 20 min continued the pattern seen at earlier timepoints. In a progressive manner, dye~toxin complex that was initially bound on one side of the monolayer was all moving toward the opposite side, presumably for release. It is encouraging that the timecourse of this morphologic analysis (e.g., Fig. 6 ) correlates well with the earlier analysis of timecourse based on capture and measurement of transcytosed material in the lower wells (e.g., Fig 5) .
DISCUSSION
Botulinum toxin is an oral poison, which means that the molecule must have an efficient mechanism to escape the lumen of the gut and reach the general circulation. A number of kinetic studies utilizing iodinated toxin have been performed in an effort to clarify the mechanism by which the toxin crosses epithelial barriers (Maksymowych and Simpson, 1998; 2004;  Maksymowych et al., submitted for publication). The results of this work indicate that the toxin penetrates cellular barriers by a specific process of binding, transcytosis, and eventual release.
The work with iodinated toxin has contributed to our understanding of epithelial transport, yet it leaves many important questions unanswered. Most obviously, the earlier studies do not localize the sites of toxin binding on the cell surface, they do not identify the paths of toxin movement through cells, and they do not localize the sites of toxin release on the contralateral surface of the cells. Therefore, the present study was undertaken to address these Visualizing the process. Botulinum toxin was labeled with a fluorescent dye (Alexa Fluor TM 488) that reacts preferentially with surface lysine residues. Both the heavy chain and the light chain of botulinum toxin type A have large numbers of exposed lysines (Fig. 7) . As indicated earlier (Methods), labeling was done under conditions that resulted in only 7-to-8 moles of dye per mole of toxin. Therefore, it was not surprising that the toxin-fluor complex retained the biological activity needed to cross epithelial barriers as well as to block neuromuscular transmission.
In relation to epithelial binding and transcytosis, a protocol was used that imposed synchrony on toxin action. The labeled molecule was incubated with cells under conditions that Visualization experiments demonstrated that endocytosed toxin moved from one cell surface to the opposite cell surface, but the path followed by the toxin was certainly not direct.
In the midsection of the cell, all transported toxin was displaced to the periphery. This was an inescapable byproduct of cell anatomy. Human gut epithelial cells have unusually large and centrally located nuclei. The transport process had to navigate around this anatomical obstacle.
Perhaps of greater interest, toxin that had made its way past the nucleus did not remain on a direct path to the basal surface. Somewhat surprisingly, at least a portion of the routes for transport moved back toward the cell midline before delivering the toxin to the basal membrane for subsequent release. These results suggest that it would be instructive to test microtubule and microfilament disruptive agents to determine the underlying mechanisms that govern the routes of transport.
Cell handling of toxin. Poisoning due to botulinum toxin involves major interactions with at least two cell types. Epithelial cells ferry the molecule from the lumen of the gut to the general circulation, and thus these can be labeled "transport cells". Peripheral cholinergic nerve endings are the principal site of toxin action, and thus they can be called "target cells". It is instructive to compare the handling of botulinum toxin by transport cells and target cells.
Black and Dolly performed the first -and thus far the only -detailed examination of botulinum toxin binding to motoneurons (Black and Dolly, 1986a; Black and Dolly, 1986b) . This elegant study demonstrated specificity and saturability of binding, and it also showed the distribution of binding sites. On the one hand, binding was largely confined to those portions of the nerve cell in close apposition to muscle; but on the other hand, binding was rather evenly distributed in these regions. At least in the latter respect, nerve cells and epithelial cells are similar. Both display binding sites across the cell surface.
There are many studies that have reported the kinetics of toxin association and dissociation with intact nerve cells or isolated membrane preparations of CNS origin (Habermann and Dreyer, 1986; Wellhöner, 1992, Halpern and Neale, 1995) . The time constants reported in the present study are apparently in keeping with this earlier literature on neuronal receptors. However, there is one aspect of epithelial binding that differs from that of neuronal binding. The experiments that quantified amount of dye~toxin binding as a function of dye~toxin concentration suggest that affinity for epithelial sites is less than that associated with neuronal sites. This possibility will require further study to confirm, but it is worth noting that there could be a plausible explanation for any differences in affinity. The principal site of toxin absorption is the upper small intestine, although binding can also occur in the stomach and distal portions of the intestine (Maksymowych et al., 1999) . This means that the potential surface area that mediates binding is enormous, and thus binding sites associated with a K d in the range of 10 -9 to 10 -7 would be highly efficient in achieving absorption. By contrast, the principal site of toxin binding in the periphery is the cholinergic nerve ending. The surface area of all peripheral motor nerve endings is miniscule compared to the surface area for toxin absorption in the gut. Therefore, the need for a lower K d to achieve a high level of affinity and a high level of toxicity is obvious.
For both neuronal cells and epithelial cells, the binding step is followed by an internalization process. It is at this point that cell handling of the toxin begins to differ dramatically. In peripheral cholinergic nerve endings, internalization involves two major events:
receptor-mediated endocytosis and pH-induced translocation to the cytosol. In addition, the structure of the molecule is altered. The interchain disulfide bond is reduced, leading to release of the catalytically active light chain. The release of active polypeptide in the immediate vicinity of the endocytosing membrane is a prelude to eventual blockade of exocytosis (Simpson, 2004) . By contrast, internalization in epithelial cells does not lead either to pH-induced translocation or to local accumulation of toxin. The visualization experiments reveal that the bulk of endocytosed toxin rapidly disappears from the vicinity of the endocytosing membrane en route to the opposite side of the cell. Furthermore, toxin released from the contralateral side of epithelial cells has no obvious structural changes. To the contrary, it must be modified experimentally (viz., disulfide bond reduction) before it will cleave isolated substrate.
The differences in toxin handling by the two cell types are a reflection of the differences in their function in systemic poisoning (Simpson, 2004) . As discussed earlier, epithelial cells can be envisioned as transport cells. The toxin binds exploitatively to them and is carried from the lumen of the gut to the general circulation. Motor neurons can be envisioned as target cells.
The toxin once again binds exploitatively, but in this instance it gains access to the cytosol and blocks exocytosis.
The fact that botulinum toxin interacts so differently with epithelial cells and with neuronal cells helps to explain the mechanisms that underlie its pharmacologic actions. 
